Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum]
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum]

Roxana Rustomjee;Alimuddin Zumla and
Infection and drug resistance 2016 Vol. 9 pp. 43-45
171
roxana2016delamanidinfection

Abstract

Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum] Rustomjee R, Zumla A. Delamanid expanded access novel treatment of drug resistant tuberculosis. Infection and Drug Resistance. 2015;8:359–366. Dr Rustomjee and Professor Zumla are grateful to a reader for raising some issues regarding referencing, and interpretation of their paper, and would like to clarify and address these issues. Read the original article 

Access

DOI:
10.2147/IDR.S101190

Citation

ID: 6322
Ref Key: roxana2016delamanidinfection
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
6322
Unique Identifier:
10.2147/IDR.S101190
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store